Search Results for "Wockhardt Europe Ltd"

22:39 EST 21st January 2017 | BioPortfolio

Matching Channels


The Scandinavian country of Sweden is home to a thriving biotechnology industry, one of the top 5 in Europe. Europe has become a global center for the industry, helped by €2 billion worth of fu...


Eligard® is a hormone compound for the treatment of advanced, hormone-dependent prostate cancer. The active ingredient (leuprolide acetate) significantly reduces the level of the male sex hormon...


AA amyloidosis affects approximately 35,000 - 50,000 individuals in the United States, Europe (Top 5 countries) and Japan. The disease occurs in a subset of patients with long-lasting inflammatory c...


At OncoDNA, our philosophy is to provide the most suitable test in terms of rapidity and cost. That’s why we follow a 3 tier approach to find tumour mutations which can respond to new cancer t...

Phoenix MarCom

Phoenix MarCom is a specialist marketing communications company, working with clients in the clean tech (including renewables, environmental technology, low carbon and sustainability), scientific an...

Matching News

Third strike for Wockhardt as API facility hit with US import alert

The US FDA has banned products from a third Indian manufacturing plant operated by Wockhardt.

Another FDA warning for Wockhardt

Wockhardt on Wednesday revealed that it had received another US Food and Drug Administration warning…

Wockhardt UK sterile site hit with FDA warning

Mumbai-based pharmaceutical and biotechnology firm Wockhardt has been hit with more manufacturing woes as the FDA issued a warning letter against the company concerning the processes at its facility i...

Wockhardt consolidated net dips by 83% in Q1 to Rs. 16 cr

Wockhardt, a Rs. 4,450 crore plus pharma major, has suffered heavy setback during the first quarter ended June 2016 and its consolidated net profit declined sharply by 82.7 per cent to Rs. 15.89 crore...

Wockhardt Introduces LabHQ LIMS for Quality Control

Global pharmaceutical and biotechnology company Wockhardt has chosen the latest version of Broughton Software’s LabHQ LIMS for its new quality control laboratories in Wrexham. This intuitive sof...

Wockhardt to up manufacturing capacity at Wrexham site

Wockhardt has said it will build a sterile manufacturing and drug testing facility at its site in Wrexham, Wales.

Data integrity and aseptic issues land Wockhardt with FDA warning

A Wockhardt facility in India put under import alert last year has received a US FDA warning letter citing issues ranging from data discrepancies to inappropriate aseptic clothing.

US FDA calls Wockhardt efforts to fix Wrexham plant 'inadequate'

Efforts by Wockhardt to fix violations at drug plant in Wrexham, Wales are inadequate according to the US FDA which detailed its concerns in a warning letter this week.

Matching PubMed Articles

Taking charge of the veterinary future in Europe.

The veterinary future in Europe was discussed at the general assembly of the Federation of Veterinarians of Europe in November. Following in the footsteps of the BVA/RCVS Vet Futures project, a simila...

One-year mortality of HIV-positive patients treated for rifampicin- and isoniazid-susceptible tuberculosis in Eastern Europe, Western Europe, and Latin America.

The high mortality among HIV/tuberculosis (TB) coinfected patients in Eastern Europe is partly explained by the high prevalence of drug-resistant TB. It remains unclear whether outcomes of HIV/TB pati...

The genetic history of Ice Age Europe.

Modern humans arrived in Europe ~45,000 years ago, but little is known about their genetic composition before the start of farming ~8,500 years ago. Here we analyse genome-wide data from 51 Eurasians ...

Dengue and other Aedes-borne viruses: a threat to Europe?

Corrigendum to "EuReCa ONE-27 Nations, ONE Europe, ONE Registry A prospective one month analysis of out-of-hospital cardiac arrest outcomes in 27 countries in Europe" Resuscitation 105 (2016) 188-195.

Search Whole site using Google

Quick Search
Advertisement Advertisement